Evidence mapPaperPMID 42347413Full record

ReviewToxics2026

Implications of Endocrine-Disrupting Chemicals for Human Health and Effective Methods for Prevention and Reduction.

Codruța-Claudia Gherman-Lencu, Teodora-Gabriela Alexescu, Cristian Mureșanu, Cezara Andreea Gerdanovics, Mircea-Vasile Milaciu, Dana-Monica Iancu

Abstract readReview
In one paragraph

Review in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Codruța-Claudia Gherman-LencuEndocrinology, Fundamental Discipline, Department 1, Iuliu Hațieganu University of Medicine and Pharmacy, Victor Babeș Street, Nr. 8, 400347 Cluj-Napoca, Romania.
Teodora-Gabriela AlexescuDepartment of Internal Medicine, 4th Medical Discipline, Iuliu Hațieganu University of Medicine and Pharmacy, Republicii Street, No. 18, 400015 Cluj-Napoca, Romania.ORCID 0000-0003-2756-5784
Cristian MureșanuLaboratory of Molecular and Biomolecular Complexes, Department of Molecular and Isotopic Technologies, National Institute for Research and Development of Isotopic and Molecular Technologies, Donat Street, Nr. 67-103, 400293 Cluj-Napoca, Romania.ORCID 0000-0002-3111-0339
Cezara Andreea GerdanovicsDepartment of Internal Medicine, 4th Medical Discipline, Iuliu Hațieganu University of Medicine and Pharmacy, Republicii Street, No. 18, 400015 Cluj-Napoca, Romania.ORCID 0009-0001-4090-0164
Mircea-Vasile MilaciuDepartment of Internal Medicine, 4th Medical Discipline, Iuliu Hațieganu University of Medicine and Pharmacy, Republicii Street, No. 18, 400015 Cluj-Napoca, Romania.
Dana-Monica IancuAnatomy, Fundamental Discipline, Department 1, Iuliu Hațieganu University of Medicine and Pharmacy, Victor Babeș Street, Nr. 8, 400347 Cluj-Napoca, Romania.ORCID 0000-0002-7523-4747

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endocrine-disrupting chemicals (EDCs) are a heterogeneous group of exogenous compounds capable of interfering with hormonal homeostasis and endocrine-regulated physiological processes. Their widespread occurrence in food, water, air, consumer products and industrial materials has raised increasing concern regarding their contribution to chronic disease burden. This review synthesizes current evidence on the exposure characteristics, molecular mechanisms, health effects, and prevention strategies related to major EDC classes, including bisphenol A and phthalates, dioxins and polychlorinated biphenyls, per- and polyfluoroalkyl substances, pesticides, and brominated flame retardants. Evidence indicates that EDCs may act through receptor-mediated signaling, altered hormone synthesis and metabolism, oxidative stress, mitochondrial dysfunction, immune modulation, and epigenetic mechanisms, with effects that may vary according to dose, timing, sex, age, and developmental susceptibility. Reported health outcomes include metabolic and cardiovascular disorders, reproductive dysfunction, hormone-dependent cancers, thyroid disruption, immune dysregulation, and adverse developmental effects. Although complete avoidance is unrealistic, exposure reduction and risk mitigation can be achieved through coordinated individual, clinical, environmental, and regulatory interventions. A life-course approach is essential to limit the health burden associated with endocrine disruption.

Indexed as

bisphenol Aendocrine-disrupting chemicals (EDCs)epigeneticgenetichormonesmetabolismobsesityprevention

Identifiers

PMID42347413
PMCPMC13307913

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.